login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AERIE PHARMACEUTICALS INC (AERI) Stock News
USA
-
Nasdaq
- NASDAQ:AERI -
US00771V1089
-
Common Stock
15.25
USD
+0.01 (+0.07%)
Last: 11/18/2022, 8:21:01 PM
15.25
USD
0 (0%)
After Hours:
11/18/2022, 8:21:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AERI Latest News, Press Relases and Analysis
All
Press Releases
3 years ago - By: Benzinga
Aerie Pharmaceuticals's Return On Capital Employed Overview
3 years ago - By: Alcon Inc. Investors
- Mentions:
ALC
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
3 years ago - By: Benzinga
- Mentions:
OCUL
CLSD
EYPT
GRAY
AiViva Reports That Their Promising New Treatment For Wet AMD Is Soon To Be Ready For Clinical Trials
3 years ago - By: Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
3 years ago - By: Kahn Swick & Foti, LLC
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
3 years ago - By: Investor's Business Daily
- Mentions:
XBI
CPRX
VRNA
CCXI
...
Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year
3 years ago - By: Aerie Pharmaceuticals, Inc.
Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options
3 years ago - By: Kahn Swick & Foti, LLC
AERIE PHARMACEUTICALS - INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI
3 years ago - By: Halper Sadeh LLP
AERI Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Aerie Pharmaceuticals, Inc. Is Fair to Shareholders
3 years ago - By: Weiss Law
- Mentions:
ALC
SHAREHOLDER ALERT: Weiss Law Investigates Aerie Pharmaceuticals, Inc.
Please enable JavaScript to continue using this application.
